Appropriateness of empirical therapy in carbapenem-resistant Klebsiella pneumoniae intensive care unit acquired infection: role of surveillance cultures

Francesco SbranaU.O. Lipoaferesi, Fondazione Toscana Gabriele Monasterio, Via Moruzzi,1 - Pisa, Italy; Correspondence[email protected]

Paolo MalcarneU.O. Anestesia e Rianimazione VI° – Pronto Soccorso, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy;

Gaia BernardeschiU.O. Anestesia e Rianimazione VI° – Pronto Soccorso, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy;

Andrea RipoliU.O. Lipoaferesi, Fondazione Toscana Gabriele Monasterio, Via Moruzzi,1 - Pisa, Italy;

Carlo TasciniU.O. Malattie Infettive, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

Click to increase image sizeClick to decrease image size

Disclosure statement

All other authors report no conflicts of interest.

Funding information

Carlo Tascini has received funds for speaking at symposia organized on behalf of Pfizer, Novartis, Merck and Astellas.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Appropriateness of empirical therapy in carbapenem-resistant Klebsiella pneumoniae intensive care unit acquired infection: role of surveillance cultures

Disclosure statement

Information for

Open access

Opportunities

Help and information

Appropriateness of empirical therapy in carbapenem-resistant Klebsiella pneumoniae intensive care unit acquired infection: role of surveillance cultures

Disclosure statement

Funding information

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature